Skip to content
Screener

Nuvation Bio NUVB Asset turnover

Asset turnover at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
0.5×0.0×
Pfizer logo
PfizerPFE
0.3×0.0×
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
0.9×-0.5×
Immunome logo
ImmunomeIMNM
0.0×
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
0.0×
Arcus Biosciences logo
Arcus BiosciencesRCUS
0.1×-0.1×

Other financials

Income statement

See full
Revenue$31.7M+556%
Gross profit$9.8M+1,340%
Operating income-$51.0M+19.7%
Net income-$62.8M-6.5%
EPS (diluted)-$0.18-5.9%

Balance sheet

See full
Cash & equivalents$258.6M+4.3%
Total debt$9.5M-83.5%
Total equity$253.9M-31.9%
Total assets$744.5M+15.0%

Cash flow

See full
Operating cash flow-$43.0M+10.8%
CapEx$254.0K+40.3%
Free cash flow-$43.2M+10.6%

Valuation

See full
Market cap$2.15B+168%
Enterprise value$1.9B+211%
P/S12.6×-43.1×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-81%-39.4pp
Net margin-88.2%-42.7pp
FCF margin-75.7%-36.6pp

Returns & leverage

See full
Return on equity-47.8%-9.8pp
Debt / equity-0.1×
Current ratio8.4×-1.0×

Where this comes from

Calculated from Nuvation Bio’s reported figures.

Based on trailing twelve months.

The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 6:55 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336646

FAQ

What is Nuvation Bio's asset turnover?
Nuvation Bio (NUVB) reported asset turnover of 0.2× in Q2 2026.
How has Nuvation Bio's asset turnover changed year-over-year?
Nuvation Bio's asset turnover increased by 957.1% year-over-year, from 0× to 0.2×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

Ask your AI about Nuvation Bio's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude